Superinvestors
Filers
Securities
Index
Dow S&P 500 Nasdaq 100
Statistics

Watchlist
Sign in
Sign out

Securities
GlaxoSmithKline Cap, Inc. 2.80 03/18/23
GlaxoSmithKline Cap, Inc. 2.80 03/18/23 filings

GlaxoSmithKline Cap, Inc. 2.80 03/18/23 filings

Shareholders
Shareholder history

Significant ownership

Insider transactions

Shareholder votes

SEC filings by GlaxoSmithKline Cap, Inc. 2.80 03/18/23 (8-K)
Type	Filed

© 2024Please share About, Alternatives, Log in, Sign up, Blog, Contact, Privacy, Terms, FAQ

Under no circumstances does any information posted on FormThirteen.com represent a recommendation to buy or sell a security. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The filers listed on this website are not affiliated with FormThirteen.com. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The filers may buy and sell securities before and after any report and information herein is published. In no event shall FormThirteen.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on FormThirteen.com, or relating to the use of, or inability to use, FormThirteen.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. FormThirteen.com is not operated by a broker, a dealer, or a registered investment adviser. The data is collected from filings made available through SEC EDGAR. SEC EDGAR filings may contain errors and can contain incomplete information.